Fermenta Biotech Ltd
BSE:506414
Fermenta Biotech Ltd
BSE:506414
Price:
340.45
INR
2.62%
Market Closed
Market Cap:
₹9.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Fermenta Biotech Ltd
BSE:506414
|
IN |
|
GPO Plus Inc
OTC:GPOX
|
US |
|
ITI Ltd
NSE:ITI
|
IN |
|
Lulu's Fashion Lounge Holdings Inc
NASDAQ:LVLU
|
US |
|
Lexinfintech Holdings Ltd
NASDAQ:LX
|
CN |
|
P
|
Petron Corp
XPHS:PCOR
|
PH |
|
Sinosteel Engineering & Technology Co Ltd
SZSE:000928
|
CN |
|
M
|
Manydev Studio SE
WSE:MAN
|
PL |
|
I
|
Intel Corp
HKEX:4335
|
US |
|
Exopharm Ltd
ASX:EX1
|
AU |
|
Care Property Invest NV
XBRU:CPINV
|
BE |
|
XOMA Corp
NASDAQ:XOMA
|
US |
|
E
|
EQB Inc
F:V22
|
CA |
|
IDI SCA
PAR:IDIP
|
FR |
|
Bellerophon Therapeutics Inc
OTC:BLPH
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Fermenta Biotech Ltd (506414)
under the Base Case is
hidden
INR.
Compared with the current market price of 340.45 INR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FERMENTA Multiples-Based Value
LOCKED
Multiples Across Competitors
FERMENTA Competitors Multiples
Fermenta Biotech Ltd Competitors
Fermenta Biotech Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Fermenta Biotech Ltd
BSE:506414
|
9.9B INR | 1.8 | 11.3 | 8 | 10 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD | 13.8 | 43.7 | 29.5 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.7 | 16.9 | 23.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
